ADCT - ADC Therapeutics S.A.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.00
DETAILS
HIGH:
$5.00
LOW:
$5.00
MEDIAN:
$5.00
CONSENSUS:
$5.00
UPSIDE:
47.49%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 81.4 | 70.8 | 69.6 | 209.9 | 33.9 | 0 | 2.3 | 1.1 | 1.8 |
| Cost of Revenue | 7.7 | 5.9 | 2.5 | 3.3 | 1.4 | 141.8 | 0 | 118.1 | 85.5 |
| Gross Profit | 73.7 | 64.9 | 67.0 | 206.6 | 32.5 | (141.8) | 2.3 | (116.9) | (83.7) |
| Operating Expenses | |||||||||
| R&D Expenses | 104.0 | 109.6 | 127.1 | 186.5 | 158.0 | 142.0 | 107.5 | 118.3 | 85.5 |
| SG&A Expenses | (6.8) | 85.9 | 105.9 | 143.5 | 136.2 | 77.2 | 14.2 | 8.6 | 7.8 |
| Other Expenses | 84.9 | 0 | 0 | 0 | 0 | (141.8) | 0 | 0.2 | 0.1 |
| Operating Expenses | 182.1 | 195.5 | 233.0 | 330.0 | 294.2 | 77.4 | 121.7 | 127.1 | 93.5 |
| Operating Income | |||||||||
| Operating Income | (108.4) | (130.7) | (166.0) | (123.3) | (261.7) | (219.3) | (119.4) | (125.9) | (91.7) |
| Interest Expense | 51.6 | 50.2 | 46.3 | 36.7 | 18.3 | 4.9 | 0.2 | 0 | 0 |
| Interest Income | 8.8 | 12.3 | 10.5 | 2.6 | 0.1 | 0.8 | 2.3 | 2.9 | 1.0 |
| Profitability | |||||||||
| EBITDA | (106.5) | (102.6) | (145.8) | (107.7) | (230.5) | (218.2) | (114.1) | (122.4) | (91.3) |
| EBIT | (108.4) | (105.9) | (149.1) | (110.1) | (233.2) | (219.0) | (115.7) | (122.9) | (91.7) |
| Income Before Tax | (142.8) | (157.7) | (200.9) | (156.9) | (251.5) | (246.0) | (115.9) | (122.9) | (89.8) |
| Income Tax Expense | (0.2) | 0.2 | 39.1 | 0.2 | (21.5) | 0.3 | 0.6 | 0.2 | 0.0 |
| Net Income | (142.6) | (157.8) | (240.1) | (157.1) | (230.0) | (246.3) | (116.5) | (123.1) | (89.9) |
| Per Share Data | |||||||||
| EPS (Basic) | -1.12 | -1.62 | -2.94 | -1.99 | -3.00 | -3.77 | -1.74 | -2.29 | -1.53 |
| EPS (Diluted) | -1.12 | -1.62 | -2.94 | -1.99 | -3.00 | -3.77 | -1.74 | -2.29 | -1.53 |
| Shares Outstanding | 127.1 | 97.2 | 81.7 | 78.2 | 76.7 | 65.4 | 66.9 | 53.8 | 58.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 261.3 | 250.9 | 278.6 | 326.4 | 466.5 | 439.2 | 115.6 | 138.8 | 262.8 | 143.7 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 29.1 | 20.3 | 25.2 | 73.0 | 32.2 | 2.7 | 2.8 | 0.4 | 1.9 | 5.9 |
| Inventory | 4.2 | 18.4 | 16.2 | 12.1 | 11.1 | 0 | 0 | 1.2 | 0.3 | 0 |
| Other Current Assets | 11.7 | 9.4 | 6.0 | 0.2 | 0 | 0.4 | 0 | 0 | 0 | 1.7 |
| Total Current Assets | 306.3 | 307.4 | 336.3 | 435.0 | 525.2 | 450.4 | 122.6 | 142.1 | 265.2 | 151.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 1.3 | 13.4 | 16.1 | 10.3 | 11.2 | 4.8 | 6.3 | 1.5 | 1.1 | 0.8 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 14.4 | 13.6 | 10.2 | 8.4 | 6.7 | 5.4 | 2.9 |
| Long-Term Investments | 0 | 0 | 1.6 | 7.6 | 41.2 | 47.9 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 15.5 | 1.2 | 0.7 | (13.5) | 0.7 | 0.4 | 0.4 | 0.3 | 0.2 | 0.1 |
| Total Non-Current Assets | 16.8 | 14.6 | 18.5 | 55.9 | 92.8 | 63.2 | 15.1 | 8.5 | 6.8 | 3.8 |
| Total Assets | 323.1 | 322.0 | 354.8 | 490.9 | 618.0 | 513.7 | 137.7 | 150.6 | 271.9 | 155.1 |
| Current Liabilities | ||||||||||
| Account Payables | 9.2 | 18.0 | 15.6 | 12.4 | 12.1 | 0 | 3.3 | 6.8 | 7.6 | 2.1 |
| Short-Term Debt | 3 | 0 | 0 | 12.5 | 6.6 | 4.6 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.8 | 2.3 | 1.8 |
| Other Current Liabilities | 58.0 | 47.5 | 37.9 | 4.1 | 14.1 | 23.6 | 0.8 | 0 | 0 | 0 |
| Total Current Liabilities | 70.2 | 80.5 | 67.7 | 81.9 | 73.9 | 40.4 | 19.9 | 22.4 | 20.5 | 9.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 436.0 | 113.6 | 112.7 | 109.7 | 125.1 | 108.0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.8 | 2.4 | 312.5 | 189.7 | 222.3 | 3.8 | 2.7 | 1.4 | 1.1 | 1.1 |
| Total Non-Current Liabilities | 438.8 | 444.2 | 435.4 | 329.5 | 377.9 | 137.8 | 6.6 | 2.0 | 2.2 | 4.5 |
| Total Liabilities | 509.0 | 524.6 | 503.0 | 411.4 | 451.9 | 178.2 | 26.5 | 24.3 | 22.8 | 14.2 |
| Stockholders' Equity | ||||||||||
| Common Stock | 11.1 | 8.4 | 7.3 | 7.3 | 6.4 | 6.3 | 4.4 | 0.4 | 0.4 | 0.3 |
| Retained Earnings | (1,635.9) | (1,493.3) | (1,335.5) | (1,095.4) | (924.9) | (694.9) | (448.6) | (332.1) | (209.0) | (119.1) |
| Accumulated Other Comprehensive Income | (0.5) | (1.4) | (0.1) | 1.8 | 102.8 | 43.0 | 5.5 | 5.7 | 5.5 | 4.6 |
| Total Stockholders' Equity | (185.8) | (202.6) | (148.2) | 79.5 | 166.1 | 335.5 | 111.2 | 126.2 | 249.2 | 140.9 |
| Total Liabilities & Equity | 323.1 | 322.0 | 354.8 | 490.9 | 618.0 | 513.7 | 137.7 | 150.6 | 271.9 | 155.1 |
| Debt Metrics | ||||||||||
| Total Debt | 439.0 | 123.0 | 124.4 | 129.8 | 139.7 | 115.1 | 5.0 | 0 | 0 | 0 |
| Net Debt | 177.7 | (127.9) | (154.2) | (196.6) | (326.8) | (324.1) | (110.5) | (138.8) | (262.8) | (143.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (142.6) | (157.8) | (240.1) | (157.1) | (230.0) | (246.3) | (116.5) | (123.1) | (89.9) |
| Depreciation & Amortization | 1.9 | 3.3 | 3.3 | 5.7 | 2.6 | 2.2 | 1.6 | 0.7 | 0.3 |
| Stock-Based Compensation | 6.9 | 6.6 | 13.5 | 50.6 | 60.5 | 37.6 | 1.1 | 0.5 | 1.0 |
| Change in Working Capital | (25.4) | 3.8 | 44.3 | (49.0) | (15.7) | 12.4 | (7.9) | 0.5 | 13.5 |
| Other Non-Cash Items | 18.0 | 20.3 | 23.2 | 11.5 | (24.7) | 25.1 | (1.2) | (0.9) | 0.0 |
| Operating Cash Flow | (141.2) | (123.8) | (118.7) | (138.3) | (233.4) | (168.7) | (121.6) | (121.4) | (74.9) |
| Investing Activities | |||||||||
| Capital Expenditure | (0.3) | (0.9) | (3.2) | (0.7) | (6.4) | (2.8) | (2.1) | (2.5) | (3.2) |
| Acquisitions | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (3.2) | (0.0) | (0.1) | (0.0) | (0.1) |
| Investing Cash Flow | 0.4 | (0.9) | (3.2) | (0.7) | (6.7) | (2.8) | (2.2) | (2.5) | (3.2) |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | (2.7) | 48.6 | 61.8 | (1.0) | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | (1.3) | 0 | 0 | (0.1) | (0.0) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.5) | 36.5 | 73.9 | 3.1 | 218.8 | 0.1 | 101.7 | (0.0) | 0 |
| Financing Cash Flow | 150.9 | 97.1 | 73.9 | (0.9) | 267.4 | 495.0 | 100.5 | (0.0) | 197.2 |
| Cash Position | |||||||||
| Net Change in Cash | 10.5 | (27.7) | (47.8) | (140.1) | 27.3 | 323.6 | (23.3) | (123.9) | 119.1 |
| Cash at Beginning | 250.9 | 278.6 | 326.4 | 466.5 | 439.2 | 115.6 | 138.8 | 262.8 | 143.7 |
| Cash at End | 261.3 | 250.9 | 278.6 | 326.4 | 466.5 | 439.2 | 115.6 | 138.8 | 262.8 |
| Free Cash Flow | (141.4) | (124.7) | (121.9) | (139.0) | (239.8) | (171.5) | (123.7) | (123.8) | (78.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 81.4 | 70.8 | 69.6 | 209.9 | 33.9 | 0 | 2.3 | 1.1 | 1.8 | |
| Gross Profit | 73.7 | 64.9 | 67.0 | 206.6 | 32.5 | (141.8) | 2.3 | (116.9) | (83.7) | |
| Operating Income | (108.4) | (130.7) | (166.0) | (123.3) | (261.7) | (219.3) | (119.4) | (125.9) | (91.7) | |
| Net Income | (142.6) | (157.8) | (240.1) | (157.1) | (230.0) | (246.3) | (116.5) | (123.1) | (89.9) | |
| EPS (Diluted) | -1.12 | -1.62 | -2.94 | -1.99 | -3.00 | -3.77 | -1.74 | -2.29 | -1.53 | |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 261.3 | 250.9 | 278.6 | 326.4 | 466.5 | 439.2 | 115.6 | 138.8 | 262.8 | 143.7 |
| Total Assets | 323.1 | 322.0 | 354.8 | 490.9 | 618.0 | 513.7 | 137.7 | 150.6 | 271.9 | 155.1 |
| Total Debt | 439.0 | 123.0 | 124.4 | 129.8 | 139.7 | 115.1 | 5.0 | 0 | 0 | 0 |
| Stockholders' Equity | (185.8) | (202.6) | (148.2) | 79.5 | 166.1 | 335.5 | 111.2 | 126.2 | 249.2 | 140.9 |
| Cash Flow | ||||||||||
| Operating Cash Flow | (141.2) | (123.8) | (118.7) | (138.3) | (233.4) | (168.7) | (121.6) | (121.4) | (74.9) | |
| Capital Expenditure | (0.3) | (0.9) | (3.2) | (0.7) | (6.4) | (2.8) | (2.1) | (2.5) | (3.2) | |
| Free Cash Flow | (141.4) | (124.7) | (121.9) | (139.0) | (239.8) | (171.5) | (123.7) | (123.8) | (78.1) | |